Location: Home
  • search
  • go
  • Relate News
  • 12/30/2025Simcere Registers Phase 1 MRCT for EGFR/c-Met Bispecific ADC SIM0610 i...
  • 12/30/2025AstraZeneca's Fasenra Approved for EGPA in China
  • 12/30/2025Innovent's Ipilimumab IBI310 for Neoadjuvant Therapy approved in China
  • 12/30/2025AstraZeneca and Daiichi Sankyo Secures Chinese Approval of Enhertu fo...
  • 12/30/2025China Rejects Tianmai Biotech's Oral Insulin Capsule ORMD-0801
  • 12/30/2025Novo Nordisk Cuts Price of Wegovy in China Ahead of Patent Expiry
  • 12/30/2025HUTCHMED's Fanregratinib NDA Granted Priority Review in China
  • 12/30/2025Ultra-Low Flu Shot Prices Highlight Intensifying Pressure on China’s ...
  • 12/30/2025Suzhou Launches China’s First Nuclear Medicine Demonstration Base
  • 12/30/2025China's Beautiful Biotech Chaos vs West's Elegant Paralysis (Asia Time...
  • 12/27/2025China Leads Globally in mRNA-Based Therapeutic Vaccine Development for...
  • 12/27/2025Coherent Licenses CBP-1018 to MultiValent Biotherapies in Major Global...
  • 12/27/2025China Approves GSK's Nucala for Maintenance Treatment of Eosinophilic ...
  • 12/27/2025Novo Nordisk's Wegovy Approved in China for Cardiovascular Risk Reduct...
  • 12/27/2025NMPA Approves Amgen/UCB's Evenity for Postmenopausal Osteoporosis
  • 12/27/2025Zai Lab's COBENFY Approve in China for Schizophrenia
  • 12/27/2025China Approves Novo Nordisk's Sogroya for Pediatric Growth Hormone Def...
  • 12/27/2025Chengdu Maxvax Biotech Completes D+ Financing Round
  • 12/27/2025Hemacell Completes Series B1 Financing to Advance Platelet Regeneratio...
  • 12/27/2025CDE Seeks Comments on Chinese Translation of ICH M8 eCTD Guidelines
  • 12/23/2025China Approves First Global CSF-1R Inhibitor Pimicotinib for Rare Join...
  • 12/23/2025T-MAXIMUM Secures FDA Approval to Advance Off-the-Shelf CAR-T Therapy
  • 12/23/2025Ipsen Expands Oncology Pipeline with Global Licensing of Simcere Zaimi...
  • 12/23/2025CSPC Announces China Approval for Daratumumab Injection
  • 12/23/2025NSCEB: US Faces Urgent Challenge to Stay Ahead of China in Biotech
  • 12/22/2025China Biopharma Licensing Slows in Value as Overseas Outbound Deals Re...
  • 12/22/2025Alphamab's IND for PD-L1/VEGFR2 Bispecific ADC JSKN027 Accepted in Chi...
  • 12/22/2025NMPA Announces Revision of Montelukast Product Labels to Strengthen Dr...
  • 12/19/2025Recent Executive Moves
  • 12/19/2025U.S. Biosecurity Provisions Could Reshape China's Role in Global Biote...
  • Page:1/375 Total number of articles:11240: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group